EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Molecular mechanisms of microRNA-301a during tumor progression and metastasis

Arya Nasimi Shad, Ali Fanoodi, Amirhosein Maharati, Iman Akhlaghipour, Meysam Moghbeli

Pathology - Research and Practice · 2023-07 · 247 · 154538

DOI: 10.1016/j.prp.2023.154538 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2023-07. Verfasst von Arya Nasimi Shad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: MicroRNAs. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 216 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is known as one of the leading causes of human deaths globally. Late diagnosis is considered as one of the main reasons for the high mortality rate among cancer patients. Therefore, the introduction of early diagnostic tumor markers can improve the efficiency of therapeutic modalities. MicroRNAs (miRNAs) have a key role in regulation of cell proliferation and apoptosis. MiRNAs deregulation has been frequently reported during tumor progressions. Since, miRNAs have a high stability in body fluids; they can be used as the reliable non-invasive tumor markers. Here, we discussed the role of miR-301a during tumor progressions. MiR-301a mainly functions as an oncogene via the modulation of transcription factors, autophagy, epithelial-mesenchymal transition (EMT), and signaling pathways. This review paves the way to suggest miR-301a as a non-invasive marker for the early tumor diagnosis. MiR-301a can also be suggested as an effective target in cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsHumansCell Line, TumorSignal TransductionTranscription FactorsBiomarkers, TumorCell ProliferationGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

CancerDiagnosisMicroRNA-301aNon-invasive

Substanzen

MicroRNAsTranscription FactorsBiomarkers, Tumor

Autor:innen und Institutionen

  • Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Student Research Committee, Faculty of Medicine, Birjand University of Medical Sciences, Mashhad, Iran.
  • Department of Medical Genetics and Molecular Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: moghbelim@mums.ac.ir.

Zitieren

APA

Nasimi Shad, A., Fanoodi, A., Maharati, A., Akhlaghipour, I., & Moghbeli, M. (2023). Molecular mechanisms of microRNA-301a during tumor progression and metastasis. Pathology - Research and Practice, 247, 154538. https://doi.org/10.1016/j.prp.2023.154538

Vancouver

Nasimi Shad A, Fanoodi A, Maharati A, Akhlaghipour I, Moghbeli M. Molecular mechanisms of microRNA-301a during tumor progression and metastasis. Pathology - Research and Practice. 2023;247:154538. doi:10.1016/j.prp.2023.154538

BibTeX
@article{NasimiShad2023,
  author = {Nasimi Shad, Arya and Fanoodi, Ali and Maharati, Amirhosein and Akhlaghipour, Iman and Moghbeli, Meysam},
  title = {Molecular mechanisms of microRNA-301a during tumor progression and metastasis},
  journal = {Pathology - Research and Practice},
  year = {2023},
  volume = {247},
  pages = {154538},
  doi = {10.1016/j.prp.2023.154538}
}
Kostenlos starten →